Combined Effect of Hypertension and Alcohol Consumption on the Risk of Death (27‑Year Cohort Prospective Study)

Aim      To study the effect of arterial hypertension (AH) in combination with frequent alcohol consumption on the formation of risk for cardiovascular death and all-cause death according to results of a 27-year prospective cohort study.

Material and methods  This 27‑year prospective cohort study of an unorganized population of the Tomsk city (1546 people aged 20–59 years, including 630 men and 916 women) investigated AH prevalence and alcohol consumption (1988–1991) and analyzed the predictive significance of the effect of AH in combination with frequent alcohol consumption on the formation of risk for all-cause and cardiovascular death. AH was diagnosed at blood pressure ≥140 / 90 mm Hg. Frequent alcohol users were defined as those who consumed alcohol more than once a week.

Results The combination of AH and frequent alcohol consumption increased the risk of all-cause death 4.1 times compared to that for persons without these risk factors (p<0.001). This was true for all age groups of the total cohort (higher relative risk, RR, was observed for persons aged 20–39 years) and for men (except for the group aged 40–59 years). RR of cardiovascular death was 5.3 (p<0.001) for frequent alcohol users with AH. It was established that frequent alcohol consumption additionally increased RR of all-cause death for persons with AH (RR 1.89; p<0.05) primarily at the expense of persons aged 20-39 years. Prediction of 27‑year survival for frequent alcohol users with AH was 35.3 %.

Conclusion      A combination of AH with frequent alcohol consumption considerably increases the risk of all-cause and cardiovascular death. Frequent alcohol consumption significantly impairs the prediction of 27-year survival for persons with AH by additionally (1.9 times) increasing the risk of all-cause death. Binary AH combinations with frequent alcohol consumption exert a more pronounced adverse effect on young men and women.

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990- 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2224–60. DOI: 10.1016/S0140-6736(12)61766-8

2. World Health Organisation. Cardiovascular diseases (CVDs). 2017. [Internet] Available at: https://www.who.int/ru/news-room/factsheets/detail/cardiovascular-diseases-(cvds)

3. Boytsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23(6):7–122. DOI: 10.15829/1560-4071-2018-6-7-122

4. World Health Organization. A global brief of hypertension. Silent killer, global public health crisis. World health day. 2013. [Document number : WHO/DCO/WHD/2013.2. Av. at: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension.pdf]

5. World Health Organisation. Alcohol. 2018. [Internet] Available at: https://www.who.int/news-room/fact-sheets/detail/alcohol

6. Muromtceva G.A., Kontsevaya A.V., Konstantinov V.V., Artamonova G.V., Gatagonova T. M., Duplyakov D.V. et al. The prevalence of non-infectious disease risk factors in the Russian population in 2012-2013. Results of the ESSE-RF study. Cardiovascular Therapy and Prevention. 2014;13(6):4–11. DOI: 10.15829/1728-8800- 2014-6-4-11

7. O’Doherty MG, Cairns K, O’Neill V, Lamrock F, Jørgensen T, Brenner H et al. Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES). European Journal of Epidemiology. 2016;31(5):455–68. DOI: 10.1007/s10654- 015-0112-8

8. Ivanova A.Yu., Dolgalev I.V. Composition of death risk according to behavioral factors (smoking, alcohol consumption) by the results of 27year prospective study. Cardiovascular Therapy and Prevention. 2017;16(5):40–5. DOI: 10.15829/1728-8800-2017-5-40-45

9. Kobyakova O.S., Deev I.A., Kulikov E.S., Starovoytova E.A., Malykh R.D., Balaganskaya M.A. et al. Chronic noncommunicable diseases: combined effects of risk factors. The Russian Journal of Preventive Medicine and Public Health. 2019;22(2):45–50. DOI: 10.17116/profmed20192202145

10. Ivanova A.Yu., Dolgalev I.V. Impact of Arterial Hypertension on the Formation of the Risk of Mortality. Results of a 27-Year Prospective Study. Kardiologiia. 2018;58(9):5–11. DOI: 10.18087/cardio.2018.9.10168

11. Palatini P, Fania C, Mos L, Mazzer A, Saladini F, Casiglia E. Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers. The American Journal of Medicine. 2017;130(8):967-974.e1. DOI: 10.1016/j.amjmed.2017.02.041

12. Kalinina A.M., Pavlova L.I., Korolkov A.E., Malkova O.A., Mukhamedzhanova R.F., Panfilova O.A. et al. Study of alcohol consumption habits in the male population of 40-59 years old and its predictive value in relation to death. Therapeutic Archive. 1988;60(10):106–10.

13. Govorin N.V., Sakharov A.V. Alcohol mortality. -Tomsk; Chita: Ivan Fedorov;2012. - 164 p. ISBN 978-5-91701-051-9

14. Kladov S.Yu., Konobeyevskaya I.N., Karpov R.S. Alcohol and premature death rates of the population of Tomsk Region. Bulletin of Siberian Medicine. 2010;9(1):126–9. DOI: 10.20538/1682-0363-2010-1-126-129

15. RLMS-HSE. The Russia Longitudinal Monitoring Survey - Higher School of Economics. 2010. Available at: https://www.cpc.unc.edu/projects/rlms-hse/

16. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a casecontrol study. The Lancet. 2016;388(10046):761–75. DOI: 10.1016/S0140-6736(16)30506-2

17. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and lowincome countries (PURE): a prospective cohort study. The Lancet. 2020;395(10226):795–808. DOI: 10.1016/S0140-6736(19)32008-2

18. Ostroumova O.D., Saperova E.V. Alcohol and arterial hypertension. Rational Pharmacotherapy in Cardiology. 2014;10(1):79–82. DOI: 10.20996/1819-6446-2014-10-1-79-82

19. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 2013;31(7):1281–357. DOI: 10.1097/01.hjh.0000431740.32696.cc

20. Moulin SRA, Mill JG, Rosa WCM, Hermisdorf SR, Caldeira L da C, Zago-Gomes e M da P. QT interval prolongation associated with low magnesium in chronic alcoholics. Drug and Alcohol Dependence. 2015;155:195–201. DOI: 10.1016/j.drugalcdep.2015.07.019

21. Seccareccia F, Pannozzo F, Dima F, Minoprio A, Menditto A, Lo Noce C et al. Heart Rate as a Predictor of Mortality: The MATISS Project. American Journal of Public Health. 2001;91(8):1258–63. DOI: 10.2105/AJPH.91.8.1258

22. Shen C-J, Kao C-H, Hsu T-Y, Chen C-Y, Lin C-L, Shih H-M. Effect of alcohol intoxication on the risk of venous thromboembolism: A nationwide retrospective cohort study. Medicine. 2017;96(42):e8041. DOI: 10.1097/MD.0000000000008041

23. Tanaka A, Cui R, Kitamura A, Liu K, Imano H, Yamagishi K et al. Heavy Alcohol Consumption is Associated with Impaired Endothelial Function: The Circulatory Risk in Communities Study (CIRCS). Journal of Atherosclerosis and Thrombosis. 2016;23(9):1047–54. DOI: 10.5551/jat.31641

24. Bleakley C, Hamilton PK, Pumb R, Harbinson M, McVeigh GE. Endothelial Function in Hypertension: Victim or Culprit? The Journal of Clinical Hypertension. 2015;17(8):651–4. DOI: 10.1111/jch.12546

25. Nakanishi R, Baskaran L, Gransar H, Budoff MJ, Achenbach S, AlMallah M et al. Relationship of Hypertension to Coronary Atherosclerosis and Cardiac Events in Patients With Coronary Computed Tomographic Angiography. Hypertension. 2017;70(2):293–9. DOI: 10.1161/HYPERTENSIONAHA.117.09402

26. Erol A, Karpyak VM. Sex and gender-related differences in alcohol use and its consequences: Contemporary knowledge and future research considerations. Drug and Alcohol Dependence. 2015;156:1–13. DOI: 10.1016/j.drugalcdep.2015.08.023

27. Praud D, Rota M, Rehm J, Shield K, Zatoński W, Hashibe M et al. Cancer incidence and mortality attributable to alcohol consumption: Alcohol Attributable Cancers. International Journal of Cancer. 2016;138(6):1380–7. DOI: 10.1002/ijc.29890

28. Erol A, Ho AM-C, Winham SJ, Karpyak VM. Sex hormones in alcohol consumption: a systematic review of evidence: Sex hormones in alcoholism. Addiction Biology. 2019;24(2):157–69. DOI: 10.1111/adb.12589